Primary record
2-(.ALPHA.(SUP 3),.ALPHA.(SUP 3),.ALPHA.(SUP 3)-TRIFLUORO-2,3-XYLIDINO)NICOTINIC ACID COMPOUND WITH 1-DEOXY-1-(METHYLAMINO)-D-GLUCITOL (1:1)
- 库存
- 1,210 克
- 纯度
- 99.3 %
- CAS
- 42461-84-7
化合物标识与属性
- CAS
- 42461-84-7
- PubChem CID
- 39212
- SMILES
- CC1=C(C=CC=C1NC2=C(C=CC=N2)C(=O)O)C(F)(F)F.CNC[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O
- Canonical SMILES
- CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.Cc1c(Nc2ncccc2C(=O)O)cccc1C(F)(F)F
名称与同义词
- FLUNIXIN MEGLUMINE
- Flunixin meglumin
- Banamine
- Flumeglumine
- 42461-84-7
- finadyne
- Flunixin-S
- Sch 14714 meglumine
- null
- Equileve
- Flunazine
- Flunine
- VetaMeg
- Resflor gold
- Banamine Paste
- Ilium Flunixil
- Flunazine-S
- Flunixin (meglumine)
- Vetameg S
- Banamine Granules
- Flunixin N-methylglucanine
- Banamine (Veterinary)
- Sch-14714 meglumine
- Flu-Nix
- Flunixin Injection
- Flunixin meglumine salt
- Flunixin Injection-S
- Banamine, Banamine-S
- Flunixin Meglumine [USAN]
- Flunixin meglumine CRS
- 8Y3JK0JW3U
- RefChem:57818
- UNII-8Y3JK0JW3U
- Flunixin meglumine (USP)
- Flunixin N-Methylglucamine
- Flunixin Meglumine Solution
- C21H28F3N3O7
- Flunixin Meglumine Injection
- Banamine [vetarynary] (TN)
- Flunixin meglumine [USAN:USP]
- SCHEMBL43691
- BSPBio_002558
- CHEBI:76144
- MLS001333159
- MLS002153985
- NSC-759583
- SPECTRUM1505113
- EINECS 255-836-0
- MFCD01725419
- MGCCHNLNRBULBU-WZTVWXICSA-N
- AC1L21A7
- orb1309402
- Sch 14714
- CHEMBL1733447
- DTXCID9025584
- DTXSID1045584
- SCHEMBL29521359
- SCHEMBL29608812
- CTK8F9789
- ERK5-3E16
- Flunixin (meglumine) (Standard)
- HY-B0386R
- 2-chloropyrimidine-4-carbonitrile
- MSK7156
- HMS2093I10
- HMS2234K05
- HMS3884J07
- Pharmakon1600-01505113
- FLUNIXIN MEGLUMINE [MART.]
- C14H11F3N2O2.C7H17NO5
- CID39212
- FLUNIXIN MEGLUMINE [USP-RS]
- HY-B0386
- CID:39212
- FLUNIXIN MEGLUMINE SALT [MI]
- MSK7156-100A
- NIH 10250
- NSC759583
- s2108
- Flunixin meglumine, >=98% (HPLC)
- AKOS015895954
- AC-6012
- CCG-213338
- CS-2460
- FF23334
- FLUNIXIN MEGLUMINE [GREEN BOOK]
- KS-5126
- NSC 759583
- KS-000010G2
- NCGC00180889-01
- FLUNIXIN MEGLUMINE [USP MONOGRAPH]
- H091
- LS-71360
- SC-18614
- SMR000875279
- SID:254561552
- AB2000512
- B1445
- Flunixin meglumine 100 microg/mL in Acetonitrile
- SW196448-3
- A11686
- D04216
- Flunixin meglumine, 98.5% - 100MG 100mg
- H10204
- K-8817
- AB00920714_05
- AB00920714_06
- 3-(5-METHYL-1H-PYRAZOL-4-YL)PROPYLAMINE
- 461F847
- A825904
- C014558
- C14-H11-F3-N2-O2.C7-H17-N-O5
- SR-05000001901
- Flunixin meglumine for veterinary use [EP monograph]
- I06-1248
- SR-05000001901-1
- SR-05000001901-3
- Flunixin meglumine Solution in Acetonitrile, 100ug/mL
- Q27145782
- (2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentaol 2-((2-methyl-3-(trifluoromethyl)phenyl)amino)nicotinate
- 1-Deoxy-1-(methylamino)-D-glucitol 2-(2-methyl-3-(perfluoromethyl)anilino)nicotinate
- (2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol;2-[2-methyl-3-(trifluoromethyl)anilino]pyridine-3-carboxylic acid
- 2-((2-Methyl-3-(trifluoromethyl)-phenyl)amino)-3-pyridinecarboxylic acid with meglumine compounded
- 2-(2-Methyl-3-trifluoromethylanilino)nicotinic Acid N-Methyl-D-glucamine Salt
- 2-(alpha(sup 3),alpha(sup 3),alpha(sup 3)-Trifluoro-2,3-xylidino)nicotinic acid compound with 1-deoxy-1-(methylamino)-D-glucitol (1:1)
- 3-Pyridinecarboxylic acid, 2-((2-methyl-3-(trifluoromethyl)phenyl)amino)-, compd. with 1-deoxy-1-(methylamino)-D-glucitol (1:1)
- 1-Deoxy-1-(methylamino)-D-glucitol 2-[2-methyl-3-(perfluoromethyl)anilino]nicotinate
- 2-[[2-Methyl-3-(trifluoromethyl)phenyl]amino]-3-pyridinecarboxylic acid meglumine salt
- Flunixin meglumine, European Pharmacopoeia (EP) Reference Standard
- 2-((2-methyl-3-(trifluoromethyl)- phenyl)amino)-3-pyridinecarboxylic acid with meglumine compounded
- 2-[[2-Methyl-3-(trifluoromethyl)phenyl]amino]-3-pyridinecarboxylic Acid 1-Deoxy-1-(methylamino)-D-glucitol
- D-Glucitol, 1-deoxy-1-(methylamino)-, 2-((2-methyl-3-(trifluoromethyl)phenyl)amino)-3-pyridinecarboxylate (salt)
- Flunixin meglumine, United States Pharmacopeia (USP) Reference Standard
- 2-(2-Methyl-3-trifluorome thylanilino)nicotinic acid N-methyl-D-glucamine salt
- Flunixin Meglumine, Pharmaceutical Secondary Standard; Certified Reference Material
- (2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentaol2-((2-methyl-3-(trifluoromethyl)phenyl)amino)nicotinate
- (2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol; 2-[2-methyl-3-(trifluoromethyl)anilino]pyridine-3-carboxylic acid
- 1-deoxy-1-(methylazaniumyl)-D-glucitol 2-{[2-methyl-3-(trifluoromethyl)phenyl]amino}nicotinate
- 2-(.ALPHA.(SUP 3),.ALPHA.(SUP 3),.ALPHA.(SUP 3)-TRIFLUORO-2,3-XYLIDINO)NICOTINIC ACID COMPOUND WITH 1-DEOXY-1-(METHYLAMINO)-D-GLUCITOL (1:1)
- 2-{[2-methyl-3-(trifluoromethyl)phenyl]amino}nicotinic acid--1-deoxy-1-(methylamino)-D-glucitol (1/1)
- 255-836-0
- D-Glucitol, 1-deoxy-1-(methylamino)-, 2-[[2-methyl-3-(trifluoromethyl)phenyl]amino]-3-pyridinecarboxylate (salt)